"Spending in Medicare comes from taxpayer dollars, so that tenfold increase in what Medicare is paying for these drugs translates into what...taxpayers are paying for," CP3 Associate Director Dr. Inma Hernandez said in an interview with local news station WPXI. Read more about Dr. Hernandez' research on rising costs of Multiple Sclerosis drugs.